These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 3658953)
1. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation]. Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864 [TBL] [Abstract][Full Text] [Related]
2. [A model of diabetes mellitus in dogs: combination of pancreas resection with intra-arterial administration of alloxan]. Agaev BA; Velikhanova DM; Gadzhiev AN Probl Endokrinol (Mosk); 1992; 38(3):46-8. PubMed ID: 1513794 [TBL] [Abstract][Full Text] [Related]
3. [Intensification of the diabetogenic effect of alloxan by protamine sulfate]. Kudriashov BA; Ul'ianov AM; Tarasov IuA Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670 [TBL] [Abstract][Full Text] [Related]
4. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats. Méndez JD; Hernández Rde H Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan. Yale JF; Grose M; Videtic GM; Marliss EB Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045 [TBL] [Abstract][Full Text] [Related]
6. [Quantitative evaluation of the sensitivity of experimental animals to the diabetogenic effect of alloxan]. Pal'chikova NA; Seliatitskaia VG; Shorin IuP Probl Endokrinol (Mosk); 1987; 33(4):65-8. PubMed ID: 3658953 [TBL] [Abstract][Full Text] [Related]